文献速递艾滋病与性传播感染

潜伏HIV-1原病毒低诱导性是治愈主要障碍

Low Inducibility of Latent Human Immunodeficiency Virus Type 1 Proviruses as a Major Barrier to Cure.
PubMed 文献 · J Infect Dis · 2021-01-01

本文讨论潜伏HIV-1储存库的检测方法及低诱导性对治愈策略的影响。QVOA检测可诱导释放病毒的细胞,IPDA检测所有完整原病毒,两者差异反映许多复制 competent原病毒不易被T细胞激活诱导。低诱导性对shock-and-kill策略构成重大障碍,现有潜伏逆转剂效果远不如T细胞激活。

要点

  • QVOA提供潜伏感染细胞频率的确定性最低估计,IPDA提供更准确的上限。
  • QVOA与IPDA间1-2个log差异部分反映许多复制 competent原病毒不易被诱导。
  • 低诱导性是shock-and-kill策略的主要问题,现有潜伏逆转剂效果远不如T细胞激活。

核心结论

  • HIV-1治愈需要发现更有效诱导病毒基因表达的方法。
  • 潜伏原病毒的低诱导性是治愈的主要障碍。

研究设计与样本

  • 本文为综述/观点文章,基于QVOA和IPDA两种检测方法讨论潜伏储存库尺寸及诱导性。

主要发现

  • QVOA检测可被T细胞激活诱导释放感染性病毒的细胞,提供潜伏感染细胞频率的最低估计。
  • IPDA检测所有遗传完整原病毒,提供比标准单扩增PCR更准确的储存库上限。
  • 中断抗逆转录病毒治疗后病毒反弹的细胞频率介于QVOA和IPDA值之间。
  • QVOA与IPDA值间1-2个log差异部分反映许多复制 competent原病毒不易被T细胞激活诱导。
  • 先前研究提示潜伏感染细胞可在体内激活增殖而不表达病毒基因,但保留后续刺激产毒能力。

临床怎么用

  • shock-and-kill策略需更有效潜伏逆转剂,现有药物逆转潜伏效果远不如T细胞激活。
  • 评估储存库大小时应理解QVOA和IPDA的互补意义。

局限性

  • 本文为观点性综述,未报告原始研究数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The latent reservoir for human immunodeficiency virus type 1 (HIV-1) in resting CD4+ T cells is a major barrier to cure. The dimensions of the reservoir problem can be defined with 2 assays. A definitive minimal estimate of the frequency of latently infected cells is provided by the quantitative viral outgrowth assay (QVOA), which detects cells that can be induced by T-cell activation to release infectious virus. In contrast, the intact proviral DNA assay (IPDA) detects all genetically intact proviruses and provides a more accurate upper limit on reservoir size than standard single-amplicon polymerase chain reaction assays which mainly detect defective proviruses. The frequency of cells capable of initiating viral rebound on interruption of antiretroviral therapy lies between the values produced by the QVOA and the IPDA. We argue here that the 1-2-log difference between QVOA and IPDA values in part reflects that the fact that many replication-competent proviruses are not readily induced by T-cell activation. Findings of earlier studies suggest that latently infected cells can be activated to proliferate in vivo without expressing viral genes. The proliferating cells nevertheless retain the ability to produce virus on subsequent stimulation. The low inducibility of latent proviruses is a major problem for the shock-and-kill strategy for curing HIV-1 infection, which uses latency-reversing agents to induce viral gene expression and render infected cells susceptible to immune clearance. The latency-reversing agents developed to date are much less effective at reversing latency than T-cell activation. Taken together, these results indicate that HIV-1 eradication will require the discovery of much more effective ways to induce viral gene expression.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Siliciano JD, Siliciano RF. Low Inducibility of Latent Human Immunodeficiency Virus Type 1 Proviruses as a Major Barrier to Cure. J Infect Dis. 2021. PMID: 33586775. doi:10.1093/infdis/jiaa649

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。